<DOC>
	<DOCNO>NCT01093755</DOCNO>
	<brief_summary>The investigator hypothesize intensive acid suppression long act high potency proton pump inhibitor ( PPI ) drug dexlansoprazole lead great decrease level inflammatory mediator ( compare conventional PPIs ) esophagus , could potentially lead decreased recurrence intestinal metaplasia follow endoscopic ablation .</brief_summary>
	<brief_title>Does Intensive Acid Suppression Reduce Esophageal Inflammation Recurrent Barrett 's Esophagus Following Ablation ?</brief_title>
	<detailed_description>Patients achieve complete remission intestinal metaplasia follow ablation randomize ( use conceal allocation , like flip coin ) either intensive acid suppression dexlansoprazole 60-90 mg/day symptom guide acid suppression escalate dos omeprazole ( 20-60 mg/day ) 6 month . Control reflux assess use 24 hour ambulatory pH monitoring . The need escalate drug dosage 3 month visit determine presence excessive acid exposure ambulatory pH monitoring . Biopsies esophageal tissue obtain baseline , 3 month 6 month follow randomization measure change inflammatory biomarkers .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Patients undergone ablation Barrett 's Esophagus ( BE ) High Grade Dysplasia ( HGD ) Low Grade Dysplasia ( LGD ) Photodynamic Therapy ( PDT ) /Radiofrequency ablation endoscopic mucosal resection endoscopic histologic evidence specialize intestinal metaplasia biopsy esophagus two successive endoscopy post ablation offer enrollment study . Inclusion criterion : 1 . Absence intestinal metaplasia endoscopy ( Narrow Band Imaging ) histology ( biopsy take gastroesophageal junction distal esophagus ) two successive surveillance endoscopy . 2 . Able consent study 3 . Males females age 1890 4 . Life expectancy 5 year great . Exclusion criterion : 1 . Pregnancy 2 . Inability consent procedure 3 . Anticoagulation therapy preclude performance ambulatory pH monitoring and/or biopsies 4 . Intolerance proton pump inhibitor 5 . Elevation Alanine aminotransferase ( ALT ) , Aspartate aminotransferase ( AST ) , ( liver enzymes ) , bilirubin alkaline phosphatase five time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>Radiofrequency ablation</keyword>
	<keyword>Patients post-radiofrequency ablation Barrett 's Esophagus .</keyword>
</DOC>